NCT03819296
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +61 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Pathologic Stage IV Cutaneous Melanoma AJCC v8
Explore clinical trials studying Pathologic Stage IV Cutaneous Melanoma AJCC v8. Study availability and eligibility vary by location and protocol.
19 public trials
6 recruiting studies
Pathologic Stage IV Cutaneous Melanoma AJCC v8 trial results
NCT05588453
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +19 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Recruiting
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
NCT05039801
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +71 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT05026983
- Conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04119024
- Conditions
- Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
- Locations
-
- City of Hope Duarte, California, United States
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Stanford Cancer Institute Stanford, California, United States
NCT04511013
- Conditions
- Acral Lentiginous Melanoma, Brain Diseases, Brain Neoplasms, +22 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
Active, not recruiting
Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases
NCT01644591
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +19 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
NCT03816332
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +42 more
- Locations
-
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
Active, not recruiting
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
NCT04462406
- Conditions
- Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, +8 more
- Locations
-
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
Active, not recruiting
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
NCT02650986
- Conditions
- Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +78 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States